TransCode Therapeutics Inc (NASDAQ:RNAZ) currently has a daily average trading volume of 945.47K but it saw 14907722 shares traded in last market. With a market cap of 4.75M USD, the company’s current market price of $0.28 came rising about 16.28 while comparing to the previous closing price of $0.24. In past 52 weeks, the stock remained buoying in the range of price level as high as $128.00 and as low as $0.22. In the recent trading on the day, stock has struck highest price mark of $0.2236 while lowest mark touched by it was $0.294.
Taking a look at 20-day trading activity of TransCode Therapeutics Inc (RNAZ) gives us an average price of $0.2639, while its current price level is -99.79% below from 52-week high level whereas it is 27.31% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4938 while that of 200 days or SMA-200 reads an average of $2.0493. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.19% during that period while stretching the period over a month that decreases to 10.32%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 39.86 which implies that the stock is in neutral territory.
Over the week, RNAZ’s stock price is moving -4.48% down while it is 4.96% when we observe its performance for the past one month. Year-to-date it is -95.83% down and over the past year, the stock is showing a downside performance of -99.52%.
Currently, TransCode Therapeutics Inc’s total number of outstanding shares is 17.27M. Company’s return on investment (ROI) stands at -1354.12% and return on equity (ROE) at -1048.70%. Stock’s beta reads 0.46. Stock has a price to book (P/B) ratio of 1.51. Its return on asset (ROA) is -334.48% on average.
